- Diagnostic Potential of Alternations of Bile Acid Profiles in the Plasma of Patients with Huntington's Disease
- Global huntingtin knockout in adult mice leads to fatal neurodegeneration that spares the pancreas
- Differential microRNA expression in the SH-SY5Y human cell model as potential biomarkers for Huntington's disease
- Attitudes towards disclosure of familial genetic risk in a Mediterranean island population - a survey of the Maltese population
- Computational Assessment of the Phytochemicals of Panax ginseng C.A. Meyer Against Dopamine Receptor D1 for Early Huntington's Disease Prophylactics
- Age- and disease-related autophagy impairment in Huntington disease: New insights from direct neuronal reprogramming
- Epidemiology of Huntington's Disease in Latin America: A Systematic Review and Meta-Analysis
- Presymptomatic Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis
- Modelling alcohol consumption in rodents using two-bottle choice home cage drinking and optional lickometry-based microstructural analysis
- Identification of imidazole-based small molecules to combat cognitive disability caused by Alzheimer's disease: A molecular docking and MD simulations based approach
- Spermidine as an epigenetic regulator of autophagy in neurodegenerative disorders
- Promoting Physical Activity in Huntington's Disease: Co-Design of a Care Partner Resource
- Huntingtin is an RNA binding protein and participates in <em>NEAT1</em>-mediated paraspeckles
- Shared patterns of glial transcriptional dysregulation link Huntington's disease and schizophrenia
- Preclinical evaluation of stereopure antisense oligonucleotides for allele-selective lowering of mutant <em>HTT</em>
- Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice
- mRNA Nuclear Clustering Leads to a Difference in Mutant Huntingtin mRNA and Protein Silencing by siRNAs <em>In Vivo</em>
- NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysis
- The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions
- Novel neuroprotective 5,6-dihydropyrido[2',1':2,3]imidazo[4,5-c]quinoline derivatives acting through cholinesterase inhibition and CB2 signaling modulation
- Saccades, pupil response and blink abnormalities in Huntington's disease patients during free viewing
- Development of the Huntington Support App (HD-eHelp study): a human-centered and co-design approach
- 6-shogaol against 3-Nitropropionic acid-induced Huntington's disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-kappaB-BDNF-Nrf2 pathway
- Dynamic undirected graphical models for time-varying clinical symptom and neuroimaging networks
- In vivo CRISPR base editing for treatment of Huntington's disease
- Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier
- Neuroinflammation: A Critical Factor in Neurodegenerative Disorders
- Superoxide dismutase and neurological disorders
- Unraveling the Complexity of Human Brain: Structure, Function in Healthy and Disease States
- Structures of small molecules bound to RNA repeat expansions that cause Huntington's disease-like 2 and myotonic dystrophy type 1
- The Role of miR-137 in Neurodegenerative Disorders
- Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice
- Visual analysis of spatial transcriptomics data with RedeViz
- Protective Proteolysis in Huntington's Disease: Unraveling the Role of Post-Translational Myristoylation of Huntingtin in Autophagy
- Speech Biomarkers in Huntington's Disease: A Longitudinal Follow-Up Study in Premanifest Mutation Carriers
- Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
- Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington's Disease
- A method for the analysis of the oligomerization profile of the Huntington's disease-associated, aggregation-prone mutant huntingtin protein by isopycnic ultracentrifugation
- The antisaccadic paradigm: A complementary neuropsychological tool in basal ganglia disorders
- Perillaldehyde alleviates polyQ-induced neurodegeneration through the induction of autophagy and mitochondrial UPR in Caenorhabditis elegans
- Dalzanemdor (SAGE-718), a novel, investigational N-methyl-D-aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose-finding studies in healthy participants and an open-label study in participants with Huntington's disease
- Influence of dietary patterns in the pathophysiology of Huntington's Disease: A literature review
- Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington's disease
- Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington's disease
- Mitochondrial targeted antioxidants as potential therapy for huntington's disease
- The evolution of mammalian Rem2: unraveling the impact of purifying selection and coevolution on protein function, and implications for human disorders
- How does the age of control individuals hinder the identification of target genes for Huntington's disease?
- Sex contribution to average age at onset of Huntington's disease depends on the number of (CAG)(n) repeats
- Mutant androgen receptor induces neurite loss and senescence independently of ARE binding in a neuronal model of SBMA
- CircHTT(2,3,4,5,6) - co-evolving with the HTT CAG-repeat tract - modulates Huntington's disease phenotypes
- Clinical Reasoning and Challenges Faced With Onset Psychotic Symptoms in a Case of Combined Huntington's Disease and Gayet-Wernicke Encephalopathy
- Research advances in huntingtin-associated protein 1 and its application prospects in diseases
- A peptide strategy for inhibiting different protein aggregation pathways
- Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits
- Refining the Language of Huntington's Disease Progression with the Huntington's Disease Integrated Staging System (HD-ISS)
- Towards Standardizing Nomenclature in Huntington's Disease Research
- Genetic Interventions for Spinocerebellar Ataxia and Huntington's Disease: A Qualitative Study of the Patient Perspective
- Aberrant Hippocampal Neuroregenerative Plasticity in Schizophrenia: Reactive Neuroblastosis as a Possible Pathocellular Mechanism of Hallucination
- Making Sense of Censored Covariates: Statistical Methods for Studies of Huntington's Disease
- Neurosurgical therapy possibilities in treatment of Huntington disease: An update
- miR-196a in the carcinogenesis and other disorders with an especial focus on its biomarker capacity
- New opportunities for antioxidants in amelioration of neurodegenerative diseases
- Saccades in Huntington's Disease
- Gray matter alterations in Huntington's disease: A meta-analysis of VBM neuroimaging studies
- Engineered Branaplam Aptamers Exploit Structural Elements from Natural Riboswitches
- Ambivalent partnership of the Drosophila posterior class Hox protein Abdominal-B with the Extradenticle and Homothorax cofactors
- The DNA Damage Checkpoint Targets the Kinetochore for Relocation of Collapsed Forks to the Periphery
- Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects
- NMR structures of small molecules bound to a model of an RNA CUG repeat expansion
- CryoViT: Efficient Segmentation of Cryogenic Electron Tomograms with Vision Foundation Models
- Decoding mitochondrial quality control mechanisms: Identifying treatment targets for enhanced cellular health
- Drug repurposing for neurodegenerative diseases
- Reduced inhibitory synaptic transmission onto striatopallidal neurons may underlie aging-related motor skill deficits
- Defective mitochondria-lysosomal axis enhances the release of extracellular vesicles containing mitochondrial DNA and proteins in Huntington's disease
- The phase coherence of the neurovascular unit is reduced in Huntington's disease
- Considerations on Medication Side Effects and Gastrointestinal Symptoms in Huntington's Disease: Comments on a Recent Case Report
- Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease
- Risk Factors and Interventions for Suicide in Huntington's Disease-A Systematic Review
- Deciphering Early and Progressive Molecular Signatures in Alzheimer's Disease through Integrated Longitudinal Proteomic and Pathway Analysis in a Rodent Model
- Focused Ultrasound-Mediated Disruption of the Blood-Brain Barrier for AAV9 Delivery in a Mouse Model of Huntington's Disease
- Exploring the Comprehensive Neuroprotective and Anticancer Potential of Afzelin
- Declining Genetic Polymorphisms of the C-terminus Merozoite Surface Protein-1 Amidst Increased Plasmodium knowlesi Transmission in Thailand
- Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model
- Brain cholesterol therapy for Huntington's disease - Does it make sense?
- Exploring the Genetic Landscape of Chorea in Infancy and Early Childhood: Implications for Diagnosis and Treatment
- Molecular Mechanisms in the Design of Novel Targeted Therapies for Neurodegenerative Diseases
- Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington's disease
- Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases
- Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders
- Exploiting the Unique Biology of <em>Caenorhabditis elegans</em> to Launch Neurodegeneration Studies in Space
- Differential diagnosis of Huntington's disease- neurological aspects of NKX2-1-related disorders
- Sex differences in Huntington's disease from a neuroinflammation perspective
- Identification of key genes and signaling pathway in the pathogenesis of Huntington's disease via bioinformatics and next generation sequencing data analysis
- Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo(1)H-MRS studies
- Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health
- Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
- Excessive STAU1 condensate drives mTOR translation and autophagy dysfunction in neurodegeneration
- Sphingosine kinase 2 regulates protein ubiquitination networks in neurons
- Effect of 3-nitropropionic acid on sirtuin gene expression in Sirt3 deficient mice
- Discovery of a CK2α'-Biased ATP-Competitive Inhibitor from a High-Throughput Screen of an Allosteric-Inhibitor-Like Compound Library
RSS Feed – Literature
HDinHD > RSS Feed – Literature